Navigation Links
Endovascular Forum and CiDA Collaborate to Launch a Collective Intelligence Instrument for Dialysis Access Physicians

BOSTON, May 22 /PRNewswire/ -- The Endovascular Forum (EVF), an IC Sciences company, and its partner, Controversies in Dialysis Access (CiDA), announced a collaboration to launch a Web-based collective intelligence instrument for advanced clinical skills development in endovascular dialysis access. The program serves the partners' shared commitment to developing more potent ways for physicians to learn from peer experiences and in so doing improve their treatment decisions and practices.

Collective intelligence instruments are a class of medical informatics instruments that apply scientific design principles to effectively engage groups of clinicians or patients in exchanging information, observations, and viewpoints to advance the community's "collective intelligence." Techniques employed for high-impact collective intelligence instruments include narrative tools, user-generated tagging, and meta-data collection.

The Endovascular Forum's online, global clinician network provides an experientially diverse community ideal for collective intelligence engagement around dialysis access. End stage renal disease and renal failure requiring dialysis is a growing global problem, affecting more than 340,000 patients in America alone in 2005. Dr. Bart Dolmatch, CiDA Co-Course Director, explained the clinical value of the instrument, "In a field as rapidly evolving and complex as endovascular dialysis access interventions, new instruments are needed to quickly interpret and disseminate clinical case observations and thus provide a kind of expertise liquidity. We believe that with EVF as a foundation, and CiDA case narratives as content, a powerful collective intelligence instrument can be built that can do just that."

The collective intelligence instrument class has theoretical foundations residing in complexity science models that show the emergence of new learning patterns through the integration of varied views. The EVF-CiDA collective intelligence instruments also derive potency from narrative science applications. Dr. Eleanor Herriman, Executive Director of the Division of Medical Information Sciences, Executive Vice President and Chief Science Officer of IC Sciences, explained, "Physician experts such as Trisha Greenhalgh have found that clinical narrative anecdotes are likely the underlying form in which medical knowledge is accumulated." The strength of the collective intelligence instrument is evident in the analysis of clinician interpretations of these narratives.

About the EVF

Founded in 1996, the Endovascular Forum is the world's longest standing medical forum dedicated to endovascular specialists. The EVF is an international case study and discussion forum developed and hosted by IC Sciences Corporation ( The EVF NGHI (next generation health Internet) community comes together to share clinical observations, findings, and cases that all serve to accelerate the awareness and adoption of the most innovative and sometimes controversial procedures among physicians in the minimally invasive medical community. To learn more about the Endovascular Forum, visit or call 866- 804-6296.

About CiDA

CiDA focuses on approaches, techniques, and devices related to the placement and management of dialysis access that are constantly evolving. Through the sharing of information and by discussing both successes and complications, practitioners can further their understanding and their skills. Controversies in Dialysis Access, now in its fifth year, offers a solid sounding board for debate on a variety of pertinent, sometimes controversial, topics. Internationally recognized experts with years of experience will emphasize new developments and current trends, and attendees will be encouraged to actively contribute to dialogue on questions of greatest concern. The Course is co-directed by Dr. Bart Dolmatch and Dr. Ingemar Davidson. This year's conference will be held in Washington DC on October 20-21, 2008. For more information, visit

About IC Sciences Corporation

IC Sciences Corporation is a closely held, private organization pioneering in the medical information sciences and informed clinical technology markets. The company's core business involves designing, developing, delivering, and advancing a series of informatics instrument classes, including care delivery, cognitive profiling, collective intelligence, therapeutic support, and performance evaluation. For more information, visit

CONTACT: IC Sciences Corporation

One Joy Street Boston, MA 02108


SOURCE IC Sciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cardium Announces InnerCools Endovascular Cooling to be Featured on Science Channels Series Cool Stuff: How It Works
2. Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Micrus Endovascular Corporation
3. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Micrus Endovascular Corporation
4. The Cardiovascular Multimedia Network (CVMD) and the International Society of Endovascular Specialists (ISES) Join Forces to Educate Practitioners Worldwide Through Electronic Media
5. The German Embassy Would Like to Draw Your Attention to the Press Release of the University of Minnesota Center for German & European Studies to Present Major Healthcare Forum
6. National Quality Forum Endorses Consensus Standards for Quality of Hospital Care
7. Euro Science Open Forum 2008 online media registration deadline ends June 30
8. GACLA, Department of Health Hosts PA Latino Health Care Forum
9. Courage Center Offers Credentialed Educational Forum on Issues of Returning Injured Employees to Work
10. Inforum Presents Panel Discussion on The Future of the U.S. Health Care System: What It Will Cost in Dollars and Quality of Care
11. 5th Annual World Health Care Congress Kicks off April 21 With Obama, Clinton, McCain Health Care Policy Advisor Presidential Health Care Agenda Forum
Post Your Comments:
(Date:11/27/2015)... , ... November 27, 2015 , ... Avid collector, Andrew ... Arbor Michigan boxing style concert posters. This is one of Joplin's most famous and ... House at the University of Michigan in Ann Arbor. The According to Hawley, "It ...
(Date:11/26/2015)... ... November 26, 2015 , ... Inevitably when people think Thanksgiving, they also ... buy during the Black Friday and Cyber Monday massage chair sales to ... Internet high and low to find the best massage chair deals, they can see ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... of workshops to discuss bioavailability and the need to integrate dose form selection ... in collaboration with OBN, the membership organization supporting and bringing together the UK’s ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, ... in the 61st annual Employee Benefits Conference. The Employee Benefits Conference was hosted ... 8th through Wednesday, November 11th, 2015. The conference was held at the Hawaii ...
(Date:11/26/2015)... ... 2015 , ... Indosoft Inc., developer and distributor of the world-class Asterisk based ... efficiency and reliability. , The new Q-Suite 6 platform is based on the latest ... itself into a specific piece of software for many key components of the suite. ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... ) ... "2016 Global Tumor Marker Testing Market: Supplier ... Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive ... offering. --> ) has ... Global Tumor Marker Testing Market: Supplier Shares ...
(Date:11/26/2015)... , Países Bajos, November 26, 2015 ... terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... inmunoterapia con la terapia fotodinámica de Bremachlorin para el ... nuevo enfoque combina la inmunoterapia con la terapia fotodinámica ... Clinical Cancer Research . --> Clinical ...
(Date:11/26/2015)... , November 26, 2015 ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced ... combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced ... has found that immunotherapy can be efficiently combined ...
Breaking Medicine Technology: